Sun, Sep 21, 2014, 6:01 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

  • maxborder20002 maxborder20002 May 6, 2004 12:08 PM Flag

    T. D' Ambra's $5.37 mil. salary

    $5.37 Mil, before options (I can only imagine how disgusting the options are). The 3 year chart would warrant that he pays the company back.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
      Pay Exercised
      Thomas D' Ambra, Ph.D., 48
      Chairman, Pres, CEO $ 5.41M $ 1.10M

    • "The point of the incentive is to reward those who make very significant contributions to the success of the company."

      You should of wrote ie: The point of the "very" significant contribution is to reward those who make contributions to the company.
      I'm all for rewarding employees when they've succeeded in their most primary duty which is increasing shareholder value. His bonus incentive plan is disgusting considering the stocks performance over the last few years. D'Ambra has received a Grasso type sweetheart deal at the huge expense of the shareholders imho.

    • The point of the incentive award was that D'Ambra created it so he would be an instant beneficiary.

    • That is just plain mean. Dr. D�Ambra created this so that all employees would be incentivized. The fact that so far few if any other employees have matched this inventive entrepreneurial skill is just another indicator of why he is such a successful leader. OT- one of the concerns I have with going overseas is just not the loss of intellectual property but the loss of critical business strategy. Just imagine with their low cost the power of India and China would have if their companies had the philosophy and culture of companies such as AMRI!

    • Wake up little suzie, wake up ......

      Dr. D is the sole recipient of the 'incentive reward' because it is an engineered accounting aberation designed to mask an absurd compensation package. Nobody else can get it since there will never be another royalty deal remotely approaching Allegra scenario - everyone using a CRO is smarter now.

      This is the end of my lessons, grasshopper. Please look back at this a few years from now - I hope you are in a better place by then. I am.

    • I am in an excellent place thank you and have no intentions of moving. Rudeness will get you no where so please use peoples full name. It�s Dr. D�Ambra! Why is it wrong to reward someone that built a billion dollar company � are you a communist?

    • Are YOU actually the great D'Ambra? Sure sounds like you're "Him"! The great Doctor may have built this million/so called billion dollar comapany up-but it apprears that it is him that is also bringing it down. It WAS his to build up, but it is NOT all his to bring down. (I realize that I have a typo in "company", but "Coma"pany actually seemed appropriate in this case!)

    • LOL! Don't look behind the curtain.

    • Sorry I missed your message�no I am not the Great Dr. �Ambra. I have had the privilege of meeting him. I would be proud to have built such a company�to be the inspiration of so many people and to have created so much wealth! You may �apprear� anything you want but the fact still remains that this company has many facets each one of which is run by dedicated professionals and has enormous potential. I also think the venture in India has great potential and will help to keep AMRI competitive. This way they can be successful by moving both their business model and culture seamlessly. This will open up a wonderful opportunity for a senior manager to move to India. I wonder who they will pick�I have heard that Dr Vogt is a rising star�thoughts?

    • AMRITHEBEST: You mentioned an AMRI venture in India. Is this about to be hardcoded? Or is it simply speculation? Thanks.

    • View More Messages
22.18-0.71(-3.10%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.